The Use of P63 Immunohistochemistry for the Identification of Squamous Cell Carcinoma of the Lung-Reference-Cited by-同舟云学术

The Use of P63 Immunohistochemistry for the Identification of Squamous Cell Carcinoma of the Lung

Published:2010-08-17 Issue:8 Volume:5 Page:e12209
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Conde Esther,Angulo Bárbara,Redondo Pilar,Toldos Oscar,García-García Elena,Suárez-Gauthier Ana,Rubio-Viqueira Belén,Marrón Carmen,García-Luján Ricardo,Sánchez-Céspedes Montse,López-Encuentra Angel,Paz-Ares Luis,López-Ríos Fernando

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. Molecular portraits of human breast tumours.;CM Perou;Nature,2000

2. Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts.;DN Hayes;J Clin Oncol,2006

3. Expression signatures in lung cancer reveal a profile for EGFR-mutant tumours and identify selective PIK3CA overexpression by gene amplification.;B Angulo;J Pathol,2008

4. World Health Organization Classification of Tumours.;E Brambilla,2004

5. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.;GV Scagliotti;J Clin Oncol,2008

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the EGFR-Mutated Lung Cancer;International Journal of Molecular Sciences;2022-06-29

2. ΔNp63 regulates a common landscape of enhancer associated genes in non-small cell lung cancer;Nature Communications;2022-02-01

3. Breaking the crosstalk of the Cellular Tumorigenic Network by low-dose combination therapy in lung cancer patient-derived xenografts;Communications Biology;2022-01-17

4. A Newly Defined Pyroptosis-Related Gene Signature for the Prognosis of Bladder Cancer;International Journal of General Medicine;2021-11

5. Breaking the Crosstalk of the Cellular Tumorigenic Network in NSCLC by a Highly Effective Drug Combination;2021-10-23